Research Radar — 2026-11-13

Generated 2026-11-13T06:09:32.703050+08:00 approved RSS sources Curated daily research digest; 18/20 primary RSS feeds and 8/8 PubMed-indexed journal feeds available. Indexing may lag publication; coverage is not exhaustive.

Methods & AI

Computational

5 selected
Computational #1 Read the annotation and sampling methods before transferring labels or interpreting composition changes.

PANGEA: an integrated cell atlas across diverse biological contexts enables systematic profiling of multicellular responses in human diseases

Nature Methods Published 2026-11-12 Peer-reviewed atlas study DOI: 10.1038/s41592-026-03295-4

Authors: Seongryong Kim; Sungmin Cheong; Suho Lee; Yeju Kim; Ronald Xie; In Gyeong Koh; Jeongwoo La; Chanwoong Hwa; Hyunsu An; Jihwan Park; Joon-Yong An; Bo Wang; Jong-Eun Park

single-cell atlas

Summary: PANGEA harmonizes a large human single-cell collection and identifies disease-associated multicellular patterns. The atlas supports comparative analysis, but observed cellular associations do not establish disease mechanisms.

Why it matters: A reusable reference for comparing cell composition across diseases.

Why for Yiru: Relevant to atlas integration and cross-disease single-cell analysis.

Computational #2 Inspect feature-link assumptions, unmatched cell types and benchmark leakage before adoption; runtime claims are author-reported.

Scalable Multi-omics Diagonal Integration from Self-Mapping

bioRxiv Subject Collection: Bioinformatics Published 2026-11-12 Preprint; not peer-reviewed DOI: 10.64898/2026.11.10.765642

Authors: Guan, L., He, C.

multimodal integration

Summary: SCALEMAP uses self-mapping to align unpaired omics modalities without cross-modal cell-anchor searches. The authors report scalable RNA, chromatin and protein integration, including a 1.5-million-profile benchmark.

Why it matters: Offers an alternative computational strategy for atlas-scale multimodal alignment.

Why for Yiru: Relevant to integrating unpaired single-cell modalities without expensive anchor matching.

Computational #3 Read as associative prioritization, not validated drug discovery. Generic interaction-network bias and incomplete model availability limit reuse.

Multimodal protein representations across human brain cell types

bioRxiv Subject Collection: Bioinformatics Published 2026-11-12 Preprint; not peer-reviewed DOI: 10.64898/2026.11.10.765762

Authors: Dong, A., Li, M. M., Ding, K., Nazeen, S., Noori, A., Huang, Y., Gao, S., Ritter, D., Afroz, J., Henderson, A. B. H., Studer, L., Luo, Y., Khurana, V., Parmigiani, G., Zitnik, M.

context-aware protein representations

Summary: SEMPER combines protein-language representations with cell-context interaction networks. It evaluates protein-complex recovery, neuronal essentiality and disease-target retrieval across human brain cell contexts.

Why it matters: Makes protein representations sensitive to cellular context rather than sequence alone.

Why for Yiru: Relevant to linking single-cell atlases with molecular function and target prioritization.

Computational #4 Check performance on your microscope, cell type and labels; computational reference masks are not a physical ground truth.

SubCellSeg: A generalist model for subcellular structure segmentation in 3D fluorescence microscopy

bioRxiv Subject Collection: Bioinformatics Published 2026-11-11 Preprint; not peer-reviewed DOI: 10.64898/2026.11.10.765799

Authors: Mishra, S., Samudre, A., Khan, A., Hookway, C., Borensztejn, A., Thirstrup, D., Chen, J., Rafelski, S., Viana, M. P.

AI microscopy

Summary: SubCellSeg jointly segments 13 subcellular structures in three-dimensional fluorescence images. The authors report improved segmentation and transfer to additional imaging contexts, with small-data fine-tuning.

Why it matters: Could reduce repeated specialist-model training for microscopy phenotyping.

Why for Yiru: Relevant to AI-enabled cellular measurement and experimental perturbation readouts.

Computational #5 Benchmark locally: reported gains vary across datasets, and some component ablations cover only one slice.

SpaAxFormer: Fine-Grained Token Modeling of Spatial Transcriptomics with Axial Transformers

bioRxiv Subject Collection: Bioinformatics Published 2026-11-11 Preprint; not peer-reviewed DOI: 10.64898/2026.11.10.765756

Authors: Lee, C., Xie, X.

spatial omics

Summary: SpaAxFormer models genes within cells and corresponding gene states across spatial neighbors using axial transformers. It evaluates imputation and spatial-domain identification across several technologies.

Why it matters: Tests gene-resolved spatial modeling instead of collapsing every cell to one token.

Why for Yiru: Relevant to spatial transcriptomics representation learning and imputation.

Biomedical discoveries

Biomedicine

2 selected
Biomedicine #1 Read the transfer and pathway-intervention experiments before borrowing this mechanism for a niche model. Clinical effectiveness and in vivo specificity require full-text scrutiny.

Extracellular vesicle-mediated CD47 transfer rewires integrin-IGF1R signaling and tumor immune remodeling to propagate cetuximab resistance.

Cell Reports (via PubMed) Published 2026-11-11 Peer-reviewed original research; indexed abstract-level assessment DOI: 10.1016/j.celrep.2026.118252

Authors: Tatsuya Sakaguchi; Juntaro Yamasaki; Yukie Hata; Momoko Yoshikawa; Tomoya Soma; Kaho Hiasa; Shunichi Yoshida; Kazuhiro Fukumura; Taiju Ando; Eiji Sugihara; Hiroyuki Nobusue; Seiji Asoda; Satoru Morikawa; Hideyuki Saya; Taneaki Nakagawa; Osamu Nagano

cell-cell communication drug response extracellular vesicles

Summary: In head and neck cancer, the authors report that extracellular vesicles transfer CD47-associated resistance between cells. CD47 supports integrin-IGF1R signaling, while ALIX helps package the cargo; inhibiting vesicle release improved cetuximab activity in the reported experiments.

Why it matters: Drug resistance can propagate through exported signaling machinery, not only through intrinsic changes in each tumor cell.

Why for Yiru: A concrete example of an extrinsic input changing recipient response, with communication routes that ligand-receptor transcript scores may miss.

Biomedicine #2 Prioritize the transport assay and APOA1 rescue design. Do not treat mouse rescue as established human treatment or infer transport rates from expression alone.

The blood-brain barrier imports diverse neuroprotective proteins through pathways impaired early in Alzheimer's disease models.

Cell (via PubMed) Published 2026-11-11 Peer-reviewed original research; indexed abstract-level assessment DOI: 10.1016/j.cell.2026.10.039

Authors: Haoyue Zhou; Jason C Maynard; Alexander J Pennacchio; Amanda Apolonio; Xi Liu; Lei Yao; Mina Negahban; Zimo Zhang; Bella Ding; Jane Oberhauser; Xinlan Wen; Myung Jin Yang; Fionna Huang; Yuichi Chayama; Sahith Doddipalli; Mylinh Bernardi; Lane Domke; Iris Lo; Jeffrey Simms; Andrew Pan; Sining Du; Ning-Sum To; Pui Shuen Wong; Duc Duong; Eddie Fox; Nicholas T Seyfried; Tom H Cheung; Tara E Tracy; Alma L Burlingame; Andrew C Yang

cell-cell communication proteomics tissue context

Summary: Bioorthogonal proteomics identified 92 circulating proteins entering mouse brain parenchyma. The authors report receptor-mediated delivery to particular cell types and impaired APOA1 transport in early 5xFAD disease; hepatic APOA1 overexpression improved reported astrocytic, synaptic and behavioral endpoints.

Why it matters: Recipient context includes selective transport across tissue barriers, which can determine whether a circulating signal reaches a cell.

Why for Yiru: Useful mechanistic grounding for separating signal availability, tissue delivery and recipient-cell response in models of extrinsic effects.

Methodology Review: Krylov exponential action: evolve one state without building every possible transition

English · About 10 minutes

Numerical-method papers inspected in full text; biochemical application inspected at primary-abstract level. Worked example is constructed and verified, not biological data. No new biological or benchmark claim.

The intuition

Suppose a model tells you the instantaneous flow between many states. You want the state distribution after one hour, starting from the distribution you actually observed. Computing a complete transition matrix answers a larger question: what would happen from every possible starting state? If there are a million states, that larger answer can be the expensive part. The useful question is whether we can follow one initial vector without building the whole map. This distinction is about numerical computation, not about learning a biological model from data.

Krylov projection builds a small space from the initial vector and repeated applications of the system matrix. These vectors encode directions that the specified start can reach algebraically. An orthonormal basis makes calculations in that space manageable. We solve a reduced evolution problem and lift its answer back to the original coordinates. The basis depends on both the operator and the starting vector; it is not a universal low-dimensional representation learned once for every future input. Saad gives the projection formula and analyzes its approximation error. [R1]

A small worked example

Consider three coordinates and a constant matrix \(A\) whose first column is \((-1,1,0)^{\top}\), second column is zero, and third column is \((0,0,-2)^{\top}\). Superscript \(\top\) means transpose, so the listed coordinates form columns. Begin with \(v=(1,0,0)^{\top}\). In this constructed example, the first coordinate loses material at unit rate and sends it to the second. The third coordinate decays if occupied, but starts empty and receives no inflow. Time is measured in units for which the transfer rate is one. These are illustrative equations, not fitted biological parameters.

The exact solution at time \(t\) is \((\exp(-t),1-\exp(-t),0)^{\top}\). Differentiate each coordinate to check the equation and substitute zero to check the initial condition. At \(t=1\) this gives approximately \((0.367879,0.632121,0)^{\top}\). The total remains one for this starting vector. Because the third column loses material outside the represented coordinates, the entire three-coordinate operator is not a conservative Markov generator. That detail matters: a property verified for this one trajectory need not hold for every initial state.

Now build the approximation by hand. The first normalized basis vector is \(v_1=(1,0,0)^{\top}\). Multiplying by \(A\) gives \((-1,1,0)^{\top}\). Remove its component along \(v_1\); the remainder is \((0,1,0)^{\top}\), which becomes \(v_2\). Applying \(A\) to \(v_2\) gives zero, so no third direction is needed. The two-dimensional space is invariant under the operator. Its reduced matrix has columns \((-1,1)^{\top}\) and \((0,0)^{\top}\). Evolving there recovers the exact three-coordinate solution after lifting.

Keeping only the first basis direction instead produces \((\exp(-t),0,0)^{\top}\). At time one, it misses 0.632121 in the second coordinate. The output looks smooth and nonnegative but is wrong. This is why an attractive curve is not an accuracy check. For an exercise, start instead from the third coordinate: its one-dimensional evolution is exact, yet the old two-dimensional basis cannot represent that starting state. Then add a small coupling into the third coordinate and observe that the original two-direction closure is lost. The example isolates input dependence and approximation dimension without requiring a large dataset.

The necessary mathematics

For a real constant square matrix \(A\) of size \(n\) and initial column vector \(v\), the linear initial-value problem is \(\dot y(t)=Ay(t)\) with \(y(0)=v\). A dot denotes differentiation with respect to time \(t\), and \(y(t)\) is the evolving vector. Its solution is \(y(t)=\exp(tA)v\). The matrix exponential is not elementwise exponentiation. Al-Mohy and Higham emphasize computing its action directly because a sparse input matrix can have a dense exponential. [R3]

For a chosen dimension \(m\), define \(\mathcal K_m(A,v)=\operatorname{span}(v,Av,\dots,A^{m-1}v)\), where span means all linear combinations and powers mean repeated matrix multiplication. Let \(V_m\) contain an orthonormal basis for this space with first column \(v/\beta\), \(H_m=V_m^{\top}AV_m\) be the projected matrix, and \(\beta=\lVert v\rVert_2\) be the Euclidean length of the nonzero starting vector. With \(e_1\) the first coordinate unit vector in the reduced space, the approximation is

\[y_m(t)=\beta V_m\exp(tH_m)e_1.\]

The subscript marks the approximation dimension, not a measured time point. An invariant Krylov space gives exact action in exact arithmetic; otherwise error control is needed. [R1]

Assumptions and failure modes

The basic construction assumes a constant linear operator and access to its products with vectors. A nonlinear biological process does not become linear because this numerical method is convenient. A local linearization adds a separate modeling approximation. For time-dependent operators, one fixed exponential generally does not give the solution. Specify that boundary before choosing software. Also distinguish a matrix with many zero entries from one that is cheap to apply: expensive on-demand interactions can still dominate each product.

Basis storage, orthogonalization, time interval and numerical tolerance all affect cost. A small subspace can work well in one problem and fail in another. Expokit uses practical stepping and error-management machinery; a single projection formula is not that full algorithm. For probability calculations, check both total mass and negative entries, but do not use those checks as a substitute for error estimation. A normalized answer can still put probability in the wrong states. The toy example deliberately exposes a large missing component rather than hiding it by renormalization. [R2]

Verified applications

Expokit documents large sparse exponential actions and transient Markov-chain calculations. Al-Mohy and Higham provide a different action algorithm based on scaling and truncated Taylor series, including use in exponential integrators. These establish the computational problem and two practical solution families. They do not establish that Krylov projection is always faster, nor that a particular modern omics workflow needs it. Algorithm comparisons should hold the requested accuracy and target output fixed. [R2] [R3]

Munsky and Khammash describe biochemical probability evolution through the chemical master equation and finite-state projection, with two systems-biology examples. Their primary abstract supports the application and the existence of truncation-error certificates. It does not justify a claim here about a particular Krylov implementation or modern single-cell benchmark. Finite-state projection limits the modeled state space; exponential-action methods address how to evolve the resulting linear system numerically. The two approximations require separate error accounting. [R4]

Possible transfers — speculative

A speculative omics use would start with an independently justified transition-rate model for a small set of molecular states, then evaluate several initial population distributions without storing every transition probability. Before scaling, compare action-based propagation with a dense reference on a small instance. Vary numerical tolerance and state-space truncation independently. A stable numerical answer cannot validate rates inferred from observational snapshots, establish causal intervention effects, or resolve missing biological states. Those are modeling and experimental questions. This proposal is a test plan, not a demonstrated application of the cited papers. [R4]

Start by asking what output is needed: one propagated vector, several initial conditions, or the full transition map. Reproduce the three-coordinate example, including its deliberately inadequate one-direction answer. Then check a small problem whose exact solution is known before trusting a large one. Record the operator convention, starting vector, elapsed time, tolerance, approximation dimension and conservation checks. The main lesson is to compute the action you need, while keeping numerical accuracy separate from the validity of the scientific model. A smaller computation is useful only when it still answers the same question.

Reading list

Page Last Updated: